These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Jain MR; Pu S; Kalra PS; Kalra SP Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat. Raposinho PD; Broqua P; Hayward A; Akinsanya K; Galyean R; Schteingart C; Junien J; Aubert ML Neuroendocrinology; 2000 Jan; 71(1):2-7. PubMed ID: 10644893 [TBL] [Abstract][Full Text] [Related]
11. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray. De Araújo JE; Huston JP; Brandão ML Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Sajdyk TJ; Schober DA; Gehlert DR Neuropharmacology; 2002 Dec; 43(7):1165-72. PubMed ID: 12504923 [TBL] [Abstract][Full Text] [Related]
13. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats. Schmitt ML; Coelho W; Lopes-de-Souza AS; Guimarães FS; Carobrez AP Neurosci Lett; 1995 Apr; 189(2):93-6. PubMed ID: 7609926 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice. Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors. Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179 [TBL] [Abstract][Full Text] [Related]
16. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat. Yang SN; Finnman UB; Fuxe K Neuroreport; 1996 Nov; 7(15-17):2701-5. PubMed ID: 8981451 [TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y Y1-receptor stimulation is required for physiological amplification of preovulatory luteinizing hormone surges. Leupen SM; Besecke LM; Levine JE Endocrinology; 1997 Jul; 138(7):2735-9. PubMed ID: 9202211 [TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Gariboldi M; Conti M; Cavaleri D; Samanin R; Vezzani A Eur J Neurosci; 1998 Feb; 10(2):757-9. PubMed ID: 9749738 [TBL] [Abstract][Full Text] [Related]
19. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. Zanoveli JM; Pobbe RL; de Bortoli VC; Carvalho MC; Brandão ML; Zangrossi H Int J Neuropsychopharmacol; 2010 Sep; 13(8):1079-88. PubMed ID: 19941697 [TBL] [Abstract][Full Text] [Related]
20. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Kask A; Rägo L; Harro J Eur J Pharmacol; 1996 Dec; 317(2-3):R3-4. PubMed ID: 8997632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]